LifeVantage Corporation Appoints Shawn Talbott Ph.D. as New Global Chief Science Officer
January 07 2014 - 8:00AM
LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to
helping people achieve healthy living through a combination of a
compelling business opportunity and scientifically validated
products, announced today that Shawn Talbott, Ph.D. has accepted
the role of Global Chief Science Officer for the company effective
January 6, 2014.
Dr. Talbott is the recipient of a dozen competitive research
awards and has published over 200 articles and 10 books on
nutrition, health and fitness. He holds a Diploma in Sports
Nutrition from the International Olympic Committee and has served
as a nutrition consultant and educator for elite-level athletes in
a variety of sports, including professional triathletes, members of
the Utah Jazz of the National Basketball Association, the United
States Ski and Snowboard Association during the 2002 Winter Olympic
Games, the Performance Enhancement Team for the United States Track
and Field Association, and the United States Olympic Training
Centers. Dr. Talbott received his M.S. in Exercise Science
from University of Massachusetts and his Ph.D. in Nutritional
Biochemistry from Rutgers University. He has completed the
Entrepreneurial Master's Program from the Massachusetts Institute
of Technology, and is a Fellow of both the American College of
Sports Medicine and the American College of Nutrition.
"We are excited to have Shawn lead our research and development
team," said LifeVantage President and Chief Executive Officer
Douglas C. Robinson. "I believe his strong background as a
researcher, author and nationally-recognized nutritionist —
combined with our strong science-based product offerings — will
enable us to continue to expand our healthy living product
offerings."
Dr. Talbott added, "I am honored to join LifeVantage — a company
with a primary mission to help people achieve their optimum level
of health. With its patented nrf2-activation product,
Protandim, as a foundation, LifeVantage is perfectly positioned for
what I view as the next phase of natural products for helping
people to perform at their peak mental and physical potential."
About LifeVantage Corporation:
LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science
and the maker of Protandim®, the Nrf2 Synergizer® patented dietary
supplement, TrueScience® Anti-Aging Cream and LifeVantage® Canine
Health, is a science-based nutraceutical company. LifeVantage is
dedicated to visionary science that looks to transform wellness and
anti-aging internally and externally with products that
dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City,
Utah. For more information about LifeVantage,
visit www.lifevantage.com.
FORWARD LOOKING STATEMENTS
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism and
satisfaction with current prospects, as well as words such as
"believe," "anticipates," "look forward to," "should" and
variations thereof, identify forward-looking statements, but their
absence does not mean that a statement is not forward-looking.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding the Company's ability to continue
growing its product base are not guarantees of performance and the
Company's actual results could differ materially from those
contained in such statements. These forward-looking statements are
based on the Company's current expectations and beliefs concerning
future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results
or outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others the risk factors discussed in greater detail in the
Company's Annual Report on Form 10-K and its Quarterly Report on
Form 10-Q under the caption "Risk Factors," and in other documents
filed by the Company from time to time with the Securities and
Exchange Commission. The Company cautions investors not to place
undue reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
CONTACT: Public Relations Contact:
John Genna, Vice President of Marketing and Communications at (801) 432-9172
Investor Relations Contact:
Cindy England, Director of Investor Relations at (801) 432-9036,
- or -
John Mills, Senior Managing Director, ICR, LLC at (310) 954-1105
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2024 to May 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From May 2023 to May 2024